These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 35404345)
21. Loss of tafazzin results in decreased myoblast differentiation in C2C12 cells: A myoblast model of Barth syndrome and cardiolipin deficiency. Lou W; Reynolds CA; Li Y; Liu J; Hüttemann M; Schlame M; Stevenson D; Strathdee D; Greenberg ML Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Aug; 1863(8):857-865. PubMed ID: 29694924 [TBL] [Abstract][Full Text] [Related]
22. Cardiolipin metabolism and its causal role in the etiology of the inherited cardiomyopathy Barth syndrome. Gaspard GJ; McMaster CR Chem Phys Lipids; 2015 Dec; 193():1-10. PubMed ID: 26415690 [TBL] [Abstract][Full Text] [Related]
23. Temporal evolution of the heart failure phenotype in Barth syndrome and treatment with elamipretide. Sabbah HN; Taylor C; Vernon HJ Future Cardiol; 2023 Mar; 19(4):211-225. PubMed ID: 37325898 [TBL] [Abstract][Full Text] [Related]
24. SS-31 treatment ameliorates cardiac mitochondrial morphology and defective mitophagy in a murine model of Barth syndrome. Russo S; De Rasmo D; Rossi R; Signorile A; Lobasso S Sci Rep; 2024 Jun; 14(1):13655. PubMed ID: 38871974 [TBL] [Abstract][Full Text] [Related]
26. Cardiolipin deficiency leads to the destabilization of mitochondrial magnesium channel MRS2 in Barth syndrome. Joshi A; Gohil VM Hum Mol Genet; 2023 Dec; 32(24):3353-3360. PubMed ID: 37721533 [TBL] [Abstract][Full Text] [Related]
27. Deletion of the cardiolipin-specific phospholipase Cld1 rescues growth and life span defects in the tafazzin mutant: implications for Barth syndrome. Ye C; Lou W; Li Y; Chatzispyrou IA; Hüttemann M; Lee I; Houtkooper RH; Vaz FM; Chen S; Greenberg ML J Biol Chem; 2014 Feb; 289(6):3114-25. PubMed ID: 24318983 [TBL] [Abstract][Full Text] [Related]
28. Cellular functions of cardiolipin in yeast. Joshi AS; Zhou J; Gohil VM; Chen S; Greenberg ML Biochim Biophys Acta; 2009 Jan; 1793(1):212-8. PubMed ID: 18725250 [TBL] [Abstract][Full Text] [Related]
29. Monolysocardiolipins accumulate in Barth syndrome but do not lead to enhanced apoptosis. Valianpour F; Mitsakos V; Schlemmer D; Towbin JA; Taylor JM; Ekert PG; Thorburn DR; Munnich A; Wanders RJ; Barth PG; Vaz FM J Lipid Res; 2005 Jun; 46(6):1182-95. PubMed ID: 15805542 [TBL] [Abstract][Full Text] [Related]
33. The Role of Cardiolipin in Cardiovascular Health. Shen Z; Ye C; McCain K; Greenberg ML Biomed Res Int; 2015; 2015():891707. PubMed ID: 26301254 [TBL] [Abstract][Full Text] [Related]
34. Barth syndrome: cellular compensation of mitochondrial dysfunction and apoptosis inhibition due to changes in cardiolipin remodeling linked to tafazzin (TAZ) gene mutation. Gonzalvez F; D'Aurelio M; Boutant M; Moustapha A; Puech JP; Landes T; Arnauné-Pelloquin L; Vial G; Taleux N; Slomianny C; Wanders RJ; Houtkooper RH; Bellenguer P; Møller IM; Gottlieb E; Vaz FM; Manfredi G; Petit PX Biochim Biophys Acta; 2013 Aug; 1832(8):1194-206. PubMed ID: 23523468 [TBL] [Abstract][Full Text] [Related]
40. Quantitative and compositional study of cardiolipin in platelets by electrospray ionization mass spectrometry: application for the identification of Barth syndrome patients. Valianpour F; Wanders RJ; Barth PG; Overmars H; van Gennip AH Clin Chem; 2002 Sep; 48(9):1390-7. PubMed ID: 12194913 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]